Novartis launched its Galaxies of Hope app, a unique digital experience created to support the neuroendocrine tumor community.
GSW, an INC Research/inVentiv Health company and industry leader in healthcare advertising, named Sonja Foster-Storch as president. Foster-Storch reports to Lisa Stockman, president of inVentiv Health Communications.
Two Omnicom Health Group agencies will have new leadership as of January 1, 2018. Mario Muredda was named CEO of Harrison and Star, and Kristin Kantak will be CEO of Biolumina.
The Inception Companies appointed Matt Giegerich, longtime CEO of WPP’s Ogilvy CommonHealth, to serve as CEO for Inception’s two largest business units.
This is a case study by TechEmergence, an artificial intelligence market research and media platform.
The CME provider Rockpointe launched the first CME-certified course ever offered on Amazon Echo through the AudioEducate platform with joint providers Potomac Center for Medical Education (PCME) and the Academy of Physicians in Clinical Research (APCR).
Continuing its efforts to address high prescription drug costs, insurer Highmark entered into a new outcomes-based contract with Boehringer Ingelheim for Jardiance (empagliflozin), an oral medicine indicated to lower blood sugar in adults with type 2 diabetes, and also to reduce the risk of cardiovascular death in adults with type 2 diabetes who have known cardiovascular disease.
Physicians and health plan executives agree that healthcare has made little progress toward value-based care since last year, according to a survey by Quest Diagnostics.
Let’s have a peek in the crystal ball 10 years into the future. What will agencies look like then? What will the marketplace look like?
Gary M. Phillips, M.D., has been made president and CEO of OrphoMed Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics.
Triumvira Immunologics appointed Sabine Chlosta, M.D., Ph.D., as chief medical officer and Jon Irvin as VP of finance.
James (Jim) Robinson is named president and CEO of Alkermes Inc. Robinson joined Alkermes from Astellas US LLC, where he served as president, Americas Operations with responsibility for the company’s operations in North and South America. Alkermes is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) […]